The Motor City is the Perfect Place to Create Disruption in the Electric Off-Road Vehicle Market

 

The Electric off-road vehicle market projection should exceed USD 400 million by 2032, driven by the growing popularity of outdoor recreational activities, particularly in North America. The all-terrain vehicle (ATV) segment growth projections trend at 15% CAGR from 2023 to 2032, fueled by the increasing number of ATV clubs worldwide. The sports electric off-road vehicle market, previously valued at USD 30 million in 2022, is expected to see significant growth due to the rising number of sports activities globally.

Due to this rapidly evolving landscape of advanced manufacturing and mobility, the disruption in the electric off-road vehicle market is palpable. With the advent of 5G, augmented technology, and a globally interconnected workforce, new technologies that are nothing short of astonishing are emerging. This growth is particularly true in Detroit, a city with a rich history in manufacturing and now a hotbed for innovation. According to a recent report, Detroit added more than 1,000 tech jobs in the metro area in 2022.

What does this mean for the future of manufacturing in Detroit? DisruptED, the podcast dedicated to exploring the disruption in advanced manufacturing and mobility, explored the ATV trend. In the latest episode, host Ron J Stefanski sat with David Ricardo Medina Álvarez, Principal CEO at LIVAQ, to discuss how his company is disrupting Detroit manufacturing through it’s line of electric ATVs.

In this episode, Stefanski and Álvarez discuss the following:

  • The journey of LIVAQ and its mission to innovate in the field of electric ATVs
  • The importance of creating opportunities for engineering students in Mexico and the US
  • The process of developing an electric ATV, from conception to production

David Ricardo Medina Álvarez is a visionary leader in advanced manufacturing. Born and raised in Mexico, he moved to Detroit to study at the College for Creative Studies, one of the top design schools in the US. Since then, he has been at the forefront of innovation in the manufacturing industry, leveraging his expertise in transportation design to create groundbreaking electric ATVs. His work at LIVAQ is not just about producing cutting-edge vehicles but also about creating opportunities for students and young engineers, fostering a new generation of innovators.

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More